Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan

BACKGROUND: Although the use of placebo in clinical trials of schizophrenia patients is controversial because of medical and ethical concerns, placebo-controlled clinical trials are commonly used in the licensing of new drugs. AIMS: The objective of this study was to assess the attitudes toward plac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugawara, Norio, Ishioka, Masamichi, Tsuchimine, Shoko, Tsuruga, Koji, Sato, Yasushi, Furukori, Hanako, Kudo, Shuhei, Tomita, Tetsu, Nakagami, Taku, Yasui-Furukori, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658191/
https://www.ncbi.nlm.nih.gov/pubmed/26600382
http://dx.doi.org/10.1371/journal.pone.0143356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658191/
https://www.ncbi.nlm.nih.gov/pubmed/26600382
http://dx.doi.org/10.1371/journal.pone.0143356

Ejemplares similares